Scroll Down

A/Prof Peter RoyceProstate Cancer Urologist

Director of Urology, The Alfred Hospital Monash University Department of Surgery Melbourne, Australia.

A/Prof Peter Royce is Australia’s most experienced Urologist using HIFU for the treatment of prostate cancer. Since the first HIFU treatment in November 2005, a select number of men have chosen HIFU, instead of radical surgery or radiation therapy, as curative primary treatment or as salvage treatment after previous radiation therapy.

HIFU is a safe, effective and minimal invasive technology for treatment of localised prostate cancer.

About HIFU

HIFU (High Intensity Focused Ultrasound) has been used extensively in USA, UK, Japan and Europe where clinical studies have shown HIFU to be a safe and effective prostate cancer treatment.

A/Prof Peter Royce is a prostate cancer surgeon, and was the first Urologist in Melbourne, Australia to use HIFU for the treatment of prostate cancer.

The outcomes of his HIFU prostate cancer treatments have been prospectively recorded and published in a peer reviewed journal Prostate International.

HIFU should be considered as a treatment option by men with early stage prostate cancer, before consenting to radical surgery or radiation treatment, otherwise the opportunity for HIFU treatment will have been overlooked and lost forever.

Why is HIFU Beneficial

HIFU offers multiple benefits including lower complications and side effects, shorter hospital stay, immediate lowering of PSA, excellent preservation of urinary function and quality of life.

The longer term prostate cancer survival rate, progression to other treatments and overall survival, are very similar to more radical treatments.

Learn More

How is HIFU Performed

Men with early stage prostate cancer are assessed prior to HIFU with a transrectal ultrasound to measure prostate size, and to check for calcification within the prostate, factors which may both impact on tissue ablation.

Patients are admitted on the day of HIFU treatment with most patients staying overnight, however some prefer a day stay procedure. The procedure is under general anaesthesia, the prostate is mapped using transrectal ultrasound imaging, prostate tissue ablation is carefully monitored in real time over 3 hours. At the completion of treatment a urinary catheter is inserted to drain urine from the bladder, and then removed 3-4 days later in the Urology Suite by our Urology Nurse.

Learn More

How Does HIFU Work

The HIFU device is the Sonablate 500 (Sonacare USA) utilising a transrectal probe which is inserted into the rectum under anaesthesia. A crystal within the probe vibrates at a specific frequency when an electric current passes through it, and this produces ultrasound waves, which are then focused using a curved ceramic plate. The ultrasound waves pass through tissue and some of the waves are reflected back to the crystal producing an image of the prostate and its surrounding structures on a computer screen, which can be monitored by the Urologist. At the same time, by increasing the intensity of the ultrasound waves and focusing the waves on a single point (like a magnifying lens), high energy is delivered to the prostate tissue, resulting in prostate tissue ablation.

Learn More

Who is Suitable

Men with localised biopsy proven prostate cancer, who understand the treatment options of robotic/radical prostatectomy, brachytherapy, radiation therapy, or active cancer surveillance, and accept the relatively minor risks of HIFU treatment, are considered suitable for HIFU.

In order to select men for HIFU treatment, you need to provide your records of PSA tests, prostate biopsy reports, MRI and PET scan images and reports. This information can be sent via our HIFU Enquiry link, for an initial no cost assessment.

If you decide to seriously consider HIFU treatment, you will be required to have a consultation with A/Prof Royce, either at Cabrini Hospital, Melbourne or via telehealth.

Learn More

Suite 51, Cabrini Hospital
183 Wattletree Road
Ph:(03) 9500 9333 Fx:(03) 9576 0112